In vitro activation of Escherichia coli prohaemolysin to the mature membrane-targeted toxin requires HlyC and a low molecular-weight cytosolic polypeptide
- PMID: 1943702
- DOI: 10.1111/j.1365-2958.1991.tb01914.x
In vitro activation of Escherichia coli prohaemolysin to the mature membrane-targeted toxin requires HlyC and a low molecular-weight cytosolic polypeptide
Abstract
The c. 110 kDa haemolysin toxin secreted by Escherichia coli and other pathogenic Gram-negative bacteria is synthesized as the non-toxic precursor, prohaemolysin (proHlyA), which is unable to target mammalian cell membranes until activated intracellularly by an unknown mechanism dependent upon the coexpressed c. 20 kDa protein, HlyC. We have established in vitro post-translational activation of proHlyA in membrane-depleted cell extract fractions from E. coli recombinant strains containing (separately) the proHlyA and HlyC proteins. In vitro activation was calcium-independent and effective over a pH range of 6 to 9 and at temperatures from 42 degrees C to 4 degrees C. HlyC cell extract was also able to activate proHlyA which had been secreted out of cells containing the export proteins HlyB and HlyD. Fractionation of HlyC cell extracts by sucrose gradient centrifugation and molecular weight chromatography revealed activating fractions as having a molecular mass of 40 kDa, suggesting that the HlyC activator is present physiologically in a multimeric form. Cell extracts containing activation-competent HlyC and proHlyA were inactive following dialysis, but activity was restored by complementation with a cell extract lacking both proteins. HlyC and proHlyA proteins which were overproduced separately from recombinant expression plasmids were inactive following purification, but activity could again be restored with a Hly-negative cell extract. These experiments demonstrated that HlyC is not sufficient for activation; an additional cellular factor is required. The cellular factor was found in enterobacteria but not other bacteria or eukaryotic cells. It was cytosolic, protease-sensitive, and behaved as a c. 10 kDa polypeptide in a number of assays including dialysis, sucrose gradient centrifugation, and gel filtration chromatography. Thus activation was possible in a defined in vitro reaction containing only purified proHlyA, HlyC, and the cellular factor. Kinetic studies in which the relative concentrations of the three components of proHlyA activation were varied suggested that neither HlyC nor the cellular factor acts as a conventional enzyme, with each participating in a finite number of activation events.
Similar articles
-
Activation of Escherichia coli prohaemolysin to the mature toxin by acyl carrier protein-dependent fatty acylation.Nature. 1991 Jun 27;351(6329):759-61. doi: 10.1038/351759a0. Nature. 1991. PMID: 2062368
-
An ordered reaction mechanism for bacterial toxin acylation by the specialized acyltransferase HlyC: formation of a ternary complex with acylACP and protoxin substrates.Mol Microbiol. 1999 Dec;34(5):887-901. doi: 10.1046/j.1365-2958.1999.01648.x. Mol Microbiol. 1999. PMID: 10594816
-
Activation of Escherichia coli prohemolysin to the membrane-targetted toxin by HlyC-directed ACP-dependent fatty acylation.FEMS Microbiol Immunol. 1992 Sep;5(1-3):37-43. doi: 10.1111/j.1574-6968.1992.tb05884.x. FEMS Microbiol Immunol. 1992. PMID: 1419113
-
E. coli hemolysin interactions with prokaryotic and eukaryotic cell membranes.Bioessays. 1992 Aug;14(8):519-25. doi: 10.1002/bies.950140804. Bioessays. 1992. PMID: 1365905 Review.
-
Hemolysin of enterohemorrhagic Escherichia coli: structure, transport, biological activity and putative role in virulence.Int J Med Microbiol. 2014 Jul;304(5-6):521-9. doi: 10.1016/j.ijmm.2014.05.005. Epub 2014 May 15. Int J Med Microbiol. 2014. PMID: 24933303 Review.
Cited by
-
Investigations on the substrate binding sites of hemolysin B, an ABC transporter, of a type 1 secretion system.Front Microbiol. 2022 Dec 1;13:1055032. doi: 10.3389/fmicb.2022.1055032. eCollection 2022. Front Microbiol. 2022. PMID: 36532430 Free PMC article.
-
Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.Mol Oral Microbiol. 2020 Jun;35(3):85-105. doi: 10.1111/omi.12284. Epub 2020 Mar 10. Mol Oral Microbiol. 2020. PMID: 32061022 Free PMC article. Review.
-
Generation of a recombinant Aggregatibacter actinomycetemcomitans RTX toxin in Escherichia coli.Gene. 2018 Sep 25;672:106-114. doi: 10.1016/j.gene.2018.06.003. Epub 2018 Jun 4. Gene. 2018. PMID: 29879499 Free PMC article.
-
An A/U-Rich Enhancer Region Is Required for High-Level Protein Secretion through the HlyA Type I Secretion System.Appl Environ Microbiol. 2017 Dec 15;84(1):e01163-17. doi: 10.1128/AEM.01163-17. Print 2018 Jan 1. Appl Environ Microbiol. 2017. PMID: 29030442 Free PMC article.
-
Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.Mol Oral Microbiol. 2016 Feb;31(1):94-105. doi: 10.1111/omi.12133. Epub 2015 Oct 12. Mol Oral Microbiol. 2016. PMID: 26352738 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
